Mylan (MYL -2.1%) trades lower thanks to an unfavorable ruling in its patent infringement suit...

|About: Mylan Inc (MYL)|By:, SA News Editor

Mylan (MYL -2.1%) trades lower thanks to an unfavorable ruling in its patent infringement suit against Sunovion Pharmaceuticals related to its Brovana respiratory drug. A New York court granted a motion related to one of Sunovion's patent defenses, and also the company's request to limit damages. Mylan says it's appealing the ruling, and will continue to pursue an injunction.